59 related articles for article (PubMed ID: 8572572)
21. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
Osmak M; Brozović A; Ambriović-Ristov A; Hadzija M; Pivcević B; Smital T
Neoplasma; 1998; 45(4):223-30. PubMed ID: 9890665
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells.
Cipák L; Paulíková H; Novotný L; Jarosová M; Rauko P
Neoplasma; 2004; 51(3):188-92. PubMed ID: 15254671
[TBL] [Abstract][Full Text] [Related]
23. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
[TBL] [Abstract][Full Text] [Related]
24. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
25. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
26. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
27. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.
Swift LP; Rephaeli A; Nudelman A; Phillips DR; Cutts SM
Cancer Res; 2006 May; 66(9):4863-71. PubMed ID: 16651442
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
31. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
32. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
Bajo AM; Schally AV; Halmos G; Nagy A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3742-8. PubMed ID: 14506166
[TBL] [Abstract][Full Text] [Related]
33. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
Harris LN; Yang L; Tang C; Yang D; Lupu R
Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
[TBL] [Abstract][Full Text] [Related]
34. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells.
Nyoung MN; Trentesaux C; Aries A; Carpentier Y; Jardillier JC; Gorisse MC; Jeannesson P
Anticancer Res; 1994; 14(3A):1203-8. PubMed ID: 8074473
[TBL] [Abstract][Full Text] [Related]
35. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
Gruber BM; Anuszewska EL; Bubko I; Goździk A; Fokt I; Priebe W
Arch Immunol Ther Exp (Warsz); 2007; 55(3):193-8. PubMed ID: 17557149
[TBL] [Abstract][Full Text] [Related]
36. Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
Pantazis P; Mendoza JT; DeJesus A; Rubin E; Kufe D; Giovanella BC
Eur J Haematol; 1994 Sep; 53(3):135-44. PubMed ID: 7925856
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines.
Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
Chem Biol Interact; 2014 Sep; 220():140-8. PubMed ID: 24998637
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.
Pantazis P; Vardeman D; Mendoza J; Early J; Kozielski A; DeJesus A; Giovanella B
Leuk Res; 1995 Jan; 19(1):43-55. PubMed ID: 7837817
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells.
Beckman RA; McFall PJ; Sikic BI; Smith SD
J Natl Cancer Inst; 1988 May; 80(5):361-5. PubMed ID: 3357201
[TBL] [Abstract][Full Text] [Related]
40. Analysis of doxorubicin uptake in single human leukemia K562 cells using capillary electrophoresis coupled with laser-induced fluorescence detection.
Deng B; Wang Z; Song J; Xiao Y; Chen D; Huang J
Anal Bioanal Chem; 2011 Oct; 401(7):2143-52. PubMed ID: 21858496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
